Literature DB >> 26427818

It's About Time ….

Jerry J Zimmerman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26427818      PMCID： PMC4593071          DOI： 10.1097/PCC.0000000000000532

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN： 1529-7535            Impact factor:   3.624


× No keyword cloud information.
  39 in total

1.  Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells.

Authors:  Jerome Galon; Denis Franchimont; Naoki Hiroi; Gregory Frey; Antje Boettner; Monika Ehrhart-Bornstein; John J O'Shea; George P Chrousos; Stefan R Bornstein
Journal:  FASEB J       Date:  2002-01       Impact factor: 5.191

2.  Mathematical morbidity in paediatric intensive care.

Authors:  Gale A Pearson
Journal:  Lancet       Date:  2003-07-19       Impact factor: 79.321

3.  Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve.

Authors:  D Annane; E Bellissant; V Sebille; O Lesieur; B Mathieu; J C Raphael; P Gajdos
Journal:  Br J Clin Pharmacol       Date:  1998-12       Impact factor: 4.335

4.  Low-dose corticosteroid treatment in septic shock: a propensity-matching study.

Authors:  Duane Funk; Steven Doucette; Amarnath Pisipati; Peter Dodek; John C Marshall; Anand Kumar
Journal:  Crit Care Med       Date:  2014-11       Impact factor: 7.598

5.  Cumulative influence of organ dysfunctions and septic state on mortality of critically ill children.

Authors:  Francis Leclerc; Stéphane Leteurtre; Alain Duhamel; Bruno Grandbastien; François Proulx; Alain Martinot; France Gauvin; Philippe Hubert; Jacques Lacroix
Journal:  Am J Respir Crit Care Med       Date:  2004-10-29       Impact factor: 21.405

6.  Corticosteroids and transition to delirium in patients with acute lung injury.

Authors:  Matthew P Schreiber; Elizabeth Colantuoni; Oscar J Bienvenu; Karin J Neufeld; Kuan-Fu Chen; Carl Shanholtz; Pedro A Mendez-Tellez; Dale M Needham
Journal:  Crit Care Med       Date:  2014-06       Impact factor: 7.598

7.  Developing a clinically feasible personalized medicine approach to pediatric septic shock.

Authors:  Hector R Wong; Natalie Z Cvijanovich; Nick Anas; Geoffrey L Allen; Neal J Thomas; Michael T Bigham; Scott L Weiss; Julie Fitzgerald; Paul A Checchia; Keith Meyer; Thomas P Shanley; Michael Quasney; Mark Hall; Rainer Gedeit; Robert J Freishtat; Jeffrey Nowak; Raj S Shekhar; Shira Gertz; Emily Dawson; Kelli Howard; Kelli Harmon; Eileen Beckman; Erin Frank; Christopher J Lindsell
Journal:  Am J Respir Crit Care Med       Date:  2015-02-01       Impact factor: 21.405

8.  Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock.

Authors:  Angel López; Jose Angel Lorente; Jay Steingrub; Jan Bakker; Angela McLuckie; Sheila Willatts; Michael Brockway; Antonio Anzueto; Laurent Holzapfel; Desmond Breen; Michael S Silverman; Jukka Takala; Jill Donaldson; Carl Arneson; Geraldine Grove; Steven Grossman; Robert Grover
Journal:  Crit Care Med       Date:  2004-01       Impact factor: 7.598

9.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Djillali Annane; Véronique Sébille; Claire Charpentier; Pierre-Edouard Bollaert; Bruno François; Jean-Michel Korach; Gilles Capellier; Yves Cohen; Elie Azoulay; Gilles Troché; Philippe Chaumet-Riffaud; Philippe Chaumet-Riffaut; Eric Bellissant
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

10.  Corticosteroids and pediatric septic shock outcomes: a risk stratified analysis.

Authors:  Sarah J Atkinson; Natalie Z Cvijanovich; Neal J Thomas; Geoffrey L Allen; Nick Anas; Michael T Bigham; Mark Hall; Robert J Freishtat; Anita Sen; Keith Meyer; Paul A Checchia; Thomas P Shanley; Jeffrey Nowak; Michael Quasney; Scott L Weiss; Sharon Banschbach; Eileen Beckman; Kelli Howard; Erin Frank; Kelli Harmon; Patrick Lahni; Christopher J Lindsell; Hector R Wong
Journal:  PLoS One       Date:  2014-11-11       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.